Drug recall · December 3, 2014
Heparin Sodium in 0.9% Sodium Chloride Injection recall
Why: Subpotent Drug: Heparin raw material was found to have low potency
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium in 0.9% Sodium Chloride Injection, 1000 USP Heparin Units, 500 mL in a VIAFLEX Plus Container, Rx only, Manufactured for Baxter Healthcare Corporation, One Baxter Parkway, Deerfield, IL 60015 by Baxter Healthcare Corporation 250 Road 144 Jayuya, Puerto Rico, 00664, NDC 0338-0431-03
- Lots / codes
Lot #: N003061; N003079; and N003087, Exp 2/29/2016
- Quantity
- 127,746 Viaflex Plus Container
- Company
- Baxter Healthcare Corp., Deerfield, IL
- Distribution
- Nationwide
- Initiated
- October 30, 2014 · Voluntary: Firm initiated
- Classified
- November 24, 2014
- Reported
- December 3, 2014
- Ended
- September 22, 2016
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.